General: Unless stated otherwise, chemicals were obtain from commercial sources and were used without further purification. Compounds 1 [1], 2 [2] and 20 [3] were prepared according to the literature procedures. Solvents were purchased from Biosolve (Valkenswaard, The Netherlands). All moisture-sensitive reactions were performed under a nitrogen atmosphere. Anhydrous THF was dried over Na/benzophenone and freshly distilled prior to use. All the other solvents were dried over molecular sieves 4 Å or 3 Å. TLC was performed on Merck precoated Silica 60 plates. Spots were visualized by UV light and 10% H 2 SO 4 in MeOH. Microwave reactions were carried out in a Biotage microwave Initiator (Uppsala, Sweden). The microwave power was limited by temperature control once the desired temperature was reached. Sealed vessels of 2-5 mL and 10-20 mL were used. Analytical HPLC runs were performed on a Shimadzu automated HPLC system with a reversed-phase column (Alltech, C8, 90 M, 5 mm, 250 L, 4.6 mm, Deerfield, IL, USA) that was equipped with an evaporative light-scattering detector (PLELS 1000, Polymer Laboratories, Amherst, MA, USA) and a UVvis detector operating at 220 nm and 250 nm. Preparative HPLC runs were performed on an Applied Biosystems workstation. Elution was effected by using a linear gradient of 5% MeCN/0.1% TFA in H 2 O to 5% H 2 O/0.1% TFA in MeCN.
1
H NMR (300 MHz) and 13 C (75.5 MHz) were performed on a Varian G-300 spectrometer. HSQC and HMBC NMR (500 MHz) were performed with a VARIAN INOVA-500. 1 H and
13
C spectra for compounds 3,
S2
4, 13 and 24 were recorded at 400 MHz on a Bruker AVANCE-400 and 300 MHz on Bruker DPX-300 instrument. The numbering for protons in the NMR characterization are shown on the molecules, due to the symmetry of the molecule it does not correspond to the numbering used for nomenclature. Electrospray mass experiments were performed in a Shimadzu LCMS QP-8000. High-resolution mass spectrometry (HRMS) analysis was performed using an Applied Biosystems 4700 MALDI TOF/TOF instrument for compound 22. Mass spectra of 3, 4 and 13 were obtained with a ThermoFisherLCQapparatus (ESI ionization) or Apex II ICR FTMS (ESI ionization-HRMS) for compound 24. LecA inhibiton assay: The lectin LecA was obtained from Sigma-Aldrich and it was FITC labeled according to the procedure of Sigma-Aldrich [4] . Microarray experiments were performed by using PamChip arrays run on a PamStation12 instrument (Pam-Gene B.V., 's-Hertogenbosch, the Netherlands). Data were obtained by realtime imaging of the fluorescence signal by a CCD camera. Images were analyzed by using BioNavigator software (Pam-Gene). Each array slide contains spots in duplicate. The fluorescence intensities were expressed in arbitrary units and the relative intensities were the average of the two duplicate spots. Aliquots of a solution of FITC-labeled LecA (20 g mL −1 ) in HEPES/PBS buffer (10 mM HEPES, 100 mM NaCl, 0.1% BSA. pH 7.4), containing different concentrations of the inhibitors were incubated for 1 h at rt and subsequently added to the glycodendrimer chip. The binding process was monitored for 2 h and the end values of the fluorescence detection were taken for the determination of the IC50 by using Prism 5 (Graphpad Software, Inc).
1 (50 mg, 0.093 mmol, 1 equiv), Pd(PPh 3 ) 4 (4 mg, 0.003 mmol, 0.04 equiv), CuI (6.5 mg, 0.003 mmol, 0.04 equiv), and PPh 3 (2.3 mg, 0.009 mmol, 0.1 equiv) were placed into the reaction flask and dried under vacuum, then the reagents were dissolved in toluene (0.6 mL) and finally ethynyltriisopropylsilane (TIPS-acetylene, 25.4 mg, 0.139 mmol, 1.5 equiv), and Et 3 N (0.2 mL) were added under nitrogen. The reaction was heated to 50 °C for 5 h. The reaction was diluted with ethyl acetate, filtered through a silica pad and the filtrate was concentrated under reduced pressure. The resulting crude was purified by flash chromatography (silica, hexane with gradient of ethyl acetate from 0 to 90%) to afford 30.3 mg (31%) of product 3 and 16.3 mg (50%) of product 4. 
1,4-bis[2-(2-methoxyethoxy)ethoxy]-2-[trimethylsilyl]ethynyl-5-iodobenzene (5) and 1,4-bis[2-(2-methoxyethoxy)ethoxy]-2,5-bis[trimethylsilyl]ethynylbenzene (6)
The bis-iodinated compound 2 (1g, 1.77 mmol), was dissolved in THF (10 mL). ethynyltrimethylsilane (TMS-acetylene, 2.6 g, 2.65 mmol), PdCl 2 (PPh 3 ) 2 (12.4 mg, 0.17 mmol, 0.1 equiv), CuI (6.74 mg, 0.35, 0.2 equiv), Et 3 N (1 mL, 4 equiv) were added to the solution. The mixture was heated under microwave irradiation at 60 °C for 20 min. After removal of the solvent the final products were purified by column chromatography to afford compound 5 (0.48 mg, 35%) and compound 6 (0.33 mg, 53%). The NMR data were in accord with those reported in literature [5] .
General Sonogashira reaction for the preparation of compounds 7, 9, 14, 16, 18.
The free alkyne compound (1 equiv) was dissolved in THF and the monoiodinated compound 5 (1.2 equiv), PdCl 2 (PPh 3 ) 2 (0.1 equiv), CuI (0.1 equiv), Et 3 N (4 equiv) were added. The mixture was heated under microwave irradiation at 60 °C for 20 min. After evaporation of the solvent, the desired product was purified by column chromatography.
General TMS-cleavage reaction for the preparation of compounds 8, 12, 15, 17, 19.
A mixture of a double TMS-protected compound (1 equiv) and K 2 CO 3 (2 equiv) in the mixed solvents MeOH/DCM (3/1) was stirred for 45 min at rt. The reaction mixture was washed with H 2 O. The aqueous layer was extracted with DCM. The combined organic layers were dried over Na 2 SO 4 , filtered and concentrated in vacuo to afford the desired product. 
1,4-bis[2-(2-methoxyethoxy)ethoxy]-2-[tert-butyldimethylsilyl]ethynyl-5-[trimethylsilyl]ethynylbenzene (7)
0
Rod 10
The protected di-unit spacer 9 (140 mg, 0.16 mmol) was dissolved in THF (10 mL) and a solution of tetra-n-butylammonium fluoride (TBAF) (100 mg, 0.32 mmol) in THF (5 mL) was added dropwise. After 2 h at rt, water (15 mL) was added to quench the reaction. The compound was extracted with DCM. The organic layer were dried over Na 2 SO 4 and filtered. The compound was purified by column chromatography to give product 10 as a yellow solid (94 mg, 84% 
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Compound 21
A mixture of 15 (68 mg, 66 µmol), galactose azide 20 (62 mg, 145 µmol), CuSO 4 ·5H 2 O (7 mg, 26 µmol), sodium ascorbate (10 mg, 53 µmol) in DMF (1.8 mL) and H 2 O (0.2 mL) was stirred in the microwave for 40 min at 80 °C. The solvent was removed in vacuo. The yellow residue (130 mg) was dissolved in DCM (15 mL) and washed three times with H 2 O and brine. The organic layer was dried over Na 2 SO 4 , filtered and concentrated in vacuo. After column chromatography the pure product 21 was obtained as a crystalline yellow solid (102 mg, 85% 
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Compound 22
Compound 21 (67 mg, 38 µmol) was dissolved in a flask with MeOH (3 mL), and NaOMe (50 µL, 0.54 mmol) was added. 
Compound 24
To a solution of 13 (5.5 mg, 0.0043 mmol, 1 equiv) in THF (0.6 mL) a 1 M solution of TBAF (1 drop, cca 10 µL) was added. The reaction was stirred at room temperature. After 1 h TLC (DCM/MeOH 8:2) indicated no starting material. Then, to the reaction mixture the following reagents were added in the following order: water (0.6 mL), TBTA (0.46 mg, 0.0008 mmol, 0.2 equiv), copper(II) sulfate pentahydrate (0.1 mg, 0.0004 mmol, 0.1 equiv), sodium ascorbate (0.34 mg, 0.0017 mmol, 0.4 equiv) and finally 23 (5 mg, 0.0108 mmol, 2.5 equiv). The reaction mixture was stirred at room temperature under a nitrogen atmosphere in the dark. After 2 h TLC (silica, hex/EA 8:2 and C18, H 2 O/MeOH 1:1) indicated no 13, one major and one minor product. Another portion of sodium ascorbate (0.4 equiv) was added and the mixture was stirred for another 16 h. The reaction was charged to a column in order to purify by size-exclusion chromatography (Sephadex LH20, MeOH). The isolated product was further purified by reverse phase chromatography (C18, water with gradient of methanol from 0% to 100%) to afford 6.2 mg (76%) of pure product. 
Synthesis of the two-unit spacer 30 starting from 3 (hydroxyl-terminated PEG chain)
The two-unit spacer 30 could be synthesized by using 2-methyl-3-butyn-2-ol (MEBYNOL) 27
to obtain the orthogonally protected intermediate 28. Removal of 2-propanol was achieved with NaOH under heterogeneous conditions. This reaction is rather critical and it must be stopped before reaching full conversion. Longer reaction times lead to full deprotection of 28 to 11. Nonetheless, under optimized conditions, 29 was isolated in 35% yields and 36% of 5 was recovered by chromatography (55% yield based on recovered starting material). As for 13, also 30 was desilylated with TBAF immediately before in situ CuAAC reactions.
Scheme S1. Synthesis of two-units spacer. a) PdCl2 (Ph3P)2, CuI, DIPEA, THF, rt, 18 h, 85%; b) NaOH, toluene, 45 °C, 6 h, 35% (55%, based on recovered starting material).; c) PdCl2(Ph3P)2, CuI, DIPEA, toluene, 3 h, 52%.
